Company profile
Ticker
VTRO
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Bio-Techne • Sana Biotechnology • Ginkgo Bioworks • Acorda Therapeutics ...
Former names
VITRO DIAGNOSTICS INC, LABTEK INC, IMPERIAL MANAGEMENT INC
SEC CIK
Corporate docs
Subsidiaries
Infinivive MD, LLC • Fitore Inc. ...
IRS number
841012042
VTRO stock data
Latest filings (excl ownership)
D
$3.00 mm in debt / options, sold $2.00 mm, 1 investor
1 Dec 23
8-K
Entry into a Material Definitive Agreement
22 Nov 23
S-1/A
IPO registration (amended)
28 Aug 23
10-Q
2023 Q3
Quarterly report
28 Aug 23
CERT
Certification of approval for exchange listing
1 Aug 23
8-A12B
Registration of securities on exchange
1 Aug 23
8-K
Entry into a Material Definitive Agreement
19 Jul 23
S-1/A
IPO registration (amended)
17 Jul 23
8-K
Material Modifications to Rights of Security Holders
7 Jul 23
S-1/A
IPO registration (amended)
29 Jun 23
Latest ownership filings
Financial summary
| Quarter (USD) | Jul 23 | Apr 23 | Jan 23 | Oct 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Oct 22 | Oct 15 | Oct 14 | Oct 13 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 285.18 k | 285.18 k | 285.18 k | 285.18 k | 285.18 k | 285.18 k |
| Cash burn (monthly) | (no burn) | (no burn) | 346.53 k | 495.56 k | 119.84 k | 234.98 k |
| Cash used (since last report) | n/a | n/a | 1.43 mm | 2.04 mm | 494.48 k | 969.55 k |
| Cash remaining | n/a | n/a | -1.14 mm | -1.76 mm | -209.30 k | -684.38 k |
| Runway (months of cash) | n/a | n/a | -3.3 | -3.6 | -1.7 | -2.9 |
Institutional ownership, Q3 2022
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|